PM, Shri Narendra Modi today addressed the CoWin Global Conclave as India offered CoWIN platform as a digital public good to the world to combat COVID19.

PM began with conveying his condolences for all the lives lost to the pandemic, in all the countries. PM remarked that there is no parallel to such a pandemic in hundred years and no nation, however powerful, can solve a challenge like this in isolation. “The biggest lesson from the COVID-19 pandemic is that for humanity and the human cause, we have to work together and move ahead together. We have to learn from each other and guide each other about our best practices” said PM. Read More

QAI has developed a new set of accreditation standards for emergency department. The standards were launched on 30th June, 2021 by Dr Shetty at a virtual event attended by more than 100 delegates. “Delegates to 72nd World Health Assembly resolution on emergency and trauma care has come to fruition with these standards. Standards are comprehensive, at times inspirational and aspirational, and drawn from several sources.

I commend this document aiming to achieve high quality and patient safety,” said the Guest of Honour Professor Dr Melinda Truesdale, Chair, Quality and Patient Safety Special Interest Group, International Federation for Emergency Medicine (IFEM) and Senior Emergency Physician and Director, Royal Melbourne and Royal Women’s Hospitals, Australia. Read More 
Check full event https://youtu.be/my19HjqZs6s

Department of  Biotechnology, Ministry of Science & Technology, Government of India has set up two Vaccine testing facilities in its Autonomous Research Institutes  National Centre for Cell Science (NCCS), Pune, and National Institute of Animal Biotechnology,(NIAB) Hyderabad as Central Drug Laboratory (CDL), for batch testing and quality control of vaccines.

Accordingly, with funding support provided by the PM-CARES Funds trust, two new vaccine testing facilities have been set up as Central Drug laboratories at DBT- NCCS, and DBT-NIAB. DBT-NCCS and DBT-NIAB  have been the pillars for many aspects of infectious disease-related work in India and have contributed to the advancement of cutting-edge research output in frontier areas of Biotechnology relevant to human health and disease.  Read More

AYUSH Minister Kiren Rijiju today launched Ayurveda dataset on The Clinical Trials Registry- India CTRI Portal. This is a significant step towards worldwide visibility for Ayurveda-based clinical trials.

While launching the portal, Mr. Rijiju has said, Ayurveda and Yoga are rich cultural heritage of India and mindset needs to change about Ayurveda and Indian traditional knowledge. He said, this mindset is wrong, that Ayurveda is not scientific. Read More

NITI Aayog Member (Health) Dr. V. K. Paul has informed that internationally developed Moderna COVID vaccine has been granted permission for restricted use, commonly known as emergency use authorisation, in the country.
 
During the media briefing, Dr. Paul said that an application received from Moderna through its Indian Subsidiary CIPLA has been granted permission. He said, this potentially opens up a clear possibility of the vaccine being imported into India in near future. Read More

Panacea Biotec announced receipt of manufacturing license from Drugs Controller General (India) for Sputnik V vaccine against COVID-19 pursuant to its collaboration with Russian Direct Investment Fund (Russia’s sovereign wealth fund). The license is a necessary condition for using Sputnik V produced by Panacea Biotec in India.

A company statement informed, “The batches produced at Panacea Biotec’s facilities at Baddi, Himachal Pradesh were earlier shipped to the Gamaleya Center in Russia for quality control. The said batches have successfully passed all the checks for quality parameters both at the Gamaleya Center in Russia and at the Central Drug Laboratory, Kasauli, Himachal Pradesh in India.” Read More

Bharat Biotech announced safety and efficacy analysis data from phase 3 clinical trials of COVAXIN today. COVAXIN has been developed by Bharat Biotech in partnership with Indian Council of Medical Research and National Institute of Virology.

The trials were conducted across 25 sites across the country on 25 thousand 800 volunteers of the age group of 18 to 98 years. COVAXIN has showed an efficacy rate of 93 per cent against severe Covid-19 disease and 65 per cent efficacy against Delta variant. Read More

The involvement of women as science leaders seems to be increasing. The percentage of women leading research projects has increased by 4 percent over two years, said a recent government report.

Women Principal Investigators (PIs) participation in research that received Extramural Research (EMR) support (support through peer-reviewed competitive grant mechanism) was 28% during 2018-19, as compared to 24% during 2016-17, according to the Directory of Extramural Research & Development (R&D) Project 2018-19 report released by the government recently. Read More

Minister of State for Chemical & Fertilizers and Ports, Shipping & Waterways (I/C) Shri Mansukh Mandaviya today visited Zydus Biotech Park at Ahmedabad.

The Minister said on Twitter that Zydus Cadila is the developer of the ‘ZyCov-D’ which will be world’s first DNA-based Covid-19 vaccine. Shri Mandaviya also visited Hester Biosciences Limited today. He informed via Twitter that Hester has inked an MoU with Bharat Biotech for production of Covaxin. Read More

Chief Minister Vijay Rupani Friday met Yogesh Poojara of Poojara Group, the Gujarat partner of ‘Coviself’, a self-testing kit for Covid-19. Yogesh Poojara and his team demonstrated the use the kit to the chief minister.

The home-based self-use Rapid Antigen Testing for diagnosis of Covid-19 was developed by MyLabs. The self-test kit has been made available in Gujarat at pharmacy stores of all the major cities of the state in collaboration with the Poojara Group. Read More

The Community Health Facility of School of Allied Health Sciences (SAHS), Delhi Pharmaceutical Sciences and Research University was inaugurated by  former Union Minister of State for Culture and Tourism and Member of Parliament Shri K.J. Alphons.

The Distress Management Collective India (DMCI) in association with India Canada Association of Kingston, the voluntary service organisations donated five Oxygen Concentrators of 10 litres capacity and pulse oxymeters. The team DMCI donated the masks made by the rehabilitated inmates of GB Road promoted by Kat-katha and DMCI to the community health facility of the University. Read More

Dr. Jaimin Vasa promoted MSME Chair at Gujarat University in the name of “Dr. Jaimin Vasa MSME Chair”.  It was inaugurated by Hon’ble Vice-Chancellor Prof. (Dr.) Himanshu Pandya on 1 st  July 2021 and signed the MoU. Gujarat University has also allotted the office infrastructure to operate from the university campus.
 
The MSME sector is a major contributor to the socio-economic development of the country and called the & "growth engine". The Indian MSMEs sector contributes about 29% towards the GDP through its national and international trade. Read More